Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
102436 trials found · Page 175 of 5122
-
Could a genetic test spare young breast cancer patients from chemo?
Disease control Not yet recruitingRationale: Around 70 to 80% of breast cancers are so-called "hormone-dependent" (HR+)/HER2-. For more than 50 years, studies have shown that chemotherapy and optimised hormonal treatments (hormone therapy), including a drug associated with ovarian suppression (OFS), improve surv…
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC
-
New combo targets hard-to-treat breast cancer in early trial
Disease control Not yet recruitingThis is a randomized phase II study to evaluate the disease control rate (DCR) of patients with metastatic or locally advanced METHYLATED 06-methylguanine-DNA methyltransferase (MGMT) with triple-negative breast cancer (TNBC) treated with Temozolomide ± Olaparib. Patients will be…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC
-
10-Year showdown: stents or pills for clogged arteries?
Disease control Not yet recruitingThe goal of this clinical trial is to compare long term efficacy of drug-eluting stent implantation compare to optimal medical treatment in patient with chronic total occlusion in a very long-term follow-up (minimum 10 years) period.
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New drug combo aims to boost radiation for early lung cancer
Disease control Not yet recruitingMajor objectives to evaluate the efficacy and safety of lparomlimab and Tuvonralimab Injection ((QL1706, an Anti-PD-1/CTLA-4 Combined Antibody)) combined with SBRT in patients with early-stage non-small cell lung cancer.
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 01, 2026 17:55 UTC
-
New score could guide ovarian cancer surgery timing
Disease control Not yet recruitingA prospective, international, multi-center, interventional trial of advanced epithelial ovarian cancer patients offered three cycles of neoadjuvant chemotherapy (NACT) and triaged with KELIM score. Patients with favorable score will undergo interval debulking surgery (IDS) follow…
Phase: NA • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jun 10, 2026 16:52 UTC
-
Shocking the gut: could a new procedure control diabetes and fatty liver?
Disease control Not yet recruitingThis study is designed to evaluate the efficacy, safety, and mechanisms of ReCET procedure in patients with T2DM and its effect on MASLD.
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
New hope for elderly lymphoma patients: triple-drug combo targets aggressive cancer
Disease control Not yet recruitingThis is a single-arm, prospective, multicenter, open-label phase Ib/II study to evaluate the safety and efficacy of polatuzumab vedotin in combination with rituximab and chidamide in previously untreated elderly patients with MYC/BCL2 double-expressor diffuse large B-cell lymphom…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC
-
New drug aims to cut blood transfusions for bone marrow disease patients
Disease control Recruiting nowThe main aim of this study is to assess how elritercept works in lowering the need for RBC (red blood cell) transfusions and how safe elritercept is when compared with epoetin alfa. Other aims are to learn if elritercept improves tiredness as reported by participants without need…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
Smart insulin systems for kids: could early use change diabetes care?
Disease control Not yet recruitingThe purpose of this study is to investigate the effect of early initiated automated insulin de-livery (AID) treatment in type diabetes in children aged 7-16 years to glycemic control, diabe-tes distress of patients and caregivers, long-term micro- and macrovascular complications …
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC
-
Magic mushroom therapy targets despair in cancer patients
Symptom relief Recruiting nowDemoralization syndrome is frequently present in palliative care and oncology patients. In particular, up to a third of patients diagnosed with cancer will experience demoralization due to their illness. The relevance of demoralization syndrome in oncology is tied to this syndrom…
Phase: PHASE1 • Sponsor: Gustavo Vazquez • Aim: Symptom relief
Last updated Jun 08, 2026 13:09 UTC
-
New combo therapy aims to shrink hard-to-treat colorectal tumors
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether a high- and low-dose radiotherapy regimen followed by anti-angiogenic TKI and anti-PD-1 antibody therapy works to treat advanced metastatic colorectal cancer. It will also evaluate long-term survival outcomes and explore potenti…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
Rural china trial uses wearables and village doctors to stop heart failure before it starts
Prevention Not yet recruitingThe purpose of this study is to prevent heart failure in older adults (aged 65-80 years) living in rural China who have atrial fibrillation but do not currently have heart failure. Because atrial fibrillation significantly increases the risk of developing heart failure , this clu…
Phase: NA • Sponsor: Jiangsu Taizhou People's Hospital • Aim: Prevention
Last updated Jun 09, 2026 12:10 UTC
-
Could a simple injection stop pancreatic leaks after surgery?
Prevention Not yet recruitingThis study is a randomized, double-blind, placebo-controlled, multicenter phase III clinical trial designed to evaluate the efficacy and safety of octreotide microspheres in preventing pancreatic fistula after distal pancreatectomy.
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Prevention
Last updated Jun 09, 2026 12:10 UTC
-
Gut health meets cancer fight: probiotic boosts breast cancer treatment?
Disease control Recruiting nowTo evaluate the efficacy and safety of compound preparation Biolosion in combination with standard neoadjuvant therapy for locally advanced triple-negative breast cancer
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 29, 2026 14:20 UTC
-
Skin stiffness test could predict diabetic foot ulcers before they start
Diagnosis Not yet recruitingDiabetes represents one of the major chronic diseases, with diabetic ulcers being a significant adverse prognosis. Approximately 80% of lower limb amputations are attributed to diabetic foot ulcers, which constitute a primary cause of patient disability and mortality, while also …
Sponsor: Peking University Third Hospital • Aim: Diagnosis
Last updated Jun 10, 2026 13:25 UTC
-
New drug aims to wipe out lingering lymphoma cells after remission
Disease control Not yet recruitingThis is a prospective, multicenter, single-arm, open-label phase 2 study designed to evaluate the efficacy and safety of chidamide maintenance in adults with newly diagnosed double-expressor diffuse large B-cell lymphoma (DLBCL) who achieve complete response after induction thera…
Phase: PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
Can a school program stop child trafficking? new trial aims to find out
Prevention Not yet recruitingAlthough the exact scope of commercial sexual exploitation of children (CSEC) remains unknown, its significant negative physical and emotional consequences for children has been well-documented. The U.S. government recognized the need for improved CSEC prevention over two decades…
Phase: NA • Sponsor: University of New Hampshire • Aim: Prevention
Last updated Jun 03, 2026 12:06 UTC
-
Ready-Made immune cells take on blood cancers in early trial
Disease control Not yet recruitingPhase 1 Open-Label Dose-Escalation and Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of ALA-101
Phase: PHASE1 • Sponsor: Arovella Therapeutics Ltd • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New hope for tough breast cancer: targeted drug HLX43 enters phase 2 trial
Disease control Not yet recruitingThis is a Phase II Study of HLX43 in Hormone Receptor Positive,HER-2 negative Locally Advanced or Metastatic Breast Cancer Patients with Disease Progression on Standard of Care. Eligible subjects will be treated with the study drug until the loss of clinical benefit, death, intol…
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
New drug may extend remission in tough lung cancer
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of adebrelimab consolidation therapy after progression-free response of concurrent chemoradiotherapy in patients with limited-stage small cell lung cancer. This study plans to enroll patients with untreated limited-stage small c…
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC